Differences Between Heterozygous Dominant and Recessive von Willebrand’s Disease Type I Expressed by Bleeding Symptoms and Combinations of Factor VIII Variables

Summary

Three families with von Willebrand’s disease (vWd) type I were investigated. A reliable identification of healthy and diseased individuals was achieved by number of bleeding symptoms, assays of bleeding time, FVIII:C (one stage and two stage), VIIIR: Ag (EIA) and ristocetin cofactor. The diagnoses - vWd or non-vWd were confirmed by laboratory indices based on predictive values of positive and negative tests, also including VIIIR: Ag (IRMA and RIA). The last mentioned two variables did not contribute to significantly better identification of vWd versus health. The best single test variable for this purpose was ristocetin cofactor. One vWd family had significantly higher levels of ristocetin cofactor and shorter bleeding time than the other two vWd families and is probably the typical example of a family transmitting classical severe vWd.

Keywords

Bleeding time - Factor VIII - Bleeding symptoms - Ristocetin cofactor - Predictive values - Diagnostic index - von Wille-brand’s disease

• References

• 1 Hoyer LW. The factor VIII complex: Structure and function. Blood 1981; 58: 1-13
• 2 European Thrombosis Research Organization (ETRO) working party on factor VIII related activities and working party on variants of von Willebrand’s disease. malmö, sweden: Feb 9-10, 1981
• 3 Zimmerman TS, Ruggeri ZM. Von Willebrand’s disease. Clin Haematol 1983; 12: 175-200
• 4 Nilsson IM, Vilhardt H, Holmberg L, Åstedt B. Association between factor VIII related antigen and plasminogen activator. Acta Med Scand 1982; 211: 105-112
• 5 Sultan J, Simeon J, Caen JP. Detection of heterozygotes in both parents of homozygous patients with von Willebrand’s disease. J Clin Pathol 1975; 28: 309-316
• 6 Zimmerman TS, Abildgaard CF, Meyer D. The factor VIII abnormality in severe von Willebrand’s disease. N Engl J Med 1979; 301: 1307-1310
• 7 Ruggeri ZM, Zimmerman TS. Classification of variant von Wille-brand’s disease subtypes by analysis of functional characteristics and multimeric composition of factor VIII/von Willebrand factor. Ann N Y Acad Sci 1981; 370: 205-209
• 8 Wahlberg T, Savidge G, Blombäck M, Wiechel B. Influence of age, sex and blood groups on 15 blood coagulation laboratory variables in a reference material composed of 80 blood donors. Vox Sang 1980; 39: 301-308
• 9 Wahlberg T. Carriers and non-carriers of haemophilia A: Multivariate analysis of pedigree data, blood coagulation variables and bleeding symptoms. Thesis, Karolinska Institute; Stockholm: 1981
• 10 Nilsson IM, Magnusson S, Borchgrevink C. The Duke and Ivy methods for determination of the bleeding time. Thrombos Diathes Haemorrh 1963; 10: 223-234
• 11 Nilsson IM, Blombäck M, Thilen A, von Francken I. Carriers of haemophilia A. Acta Med Scand 1959; 165: 357-370
• 12 Savidge GF, Blombäck M, Blombäck B. Studies of F VIII procoagu-lant activity in plasma and concentrates using a semiautomated thrombin generation assay. Thromb Res 1979; 16: 355-365
• 13 Zimmerman TS, Ratnoff OD, Powell AE. Immunological differ-entiation of classic hemophilia (factor VIII deficiency) and von Willebrand’s disease. J Clin Invest 1971; 50: 244-254
• 14 Savidge GF, Carlebjörk G. An optimized radioimmunoassay of F VUI-related antigen (F VIII: Ag) in plasma and eluates. Thromb Res 1979; 14: 363-376
• 15 Hoyer LW. Immunologic studies of antihemophilic factor (AHF; factor VIII). IV Radioimmunoassay of AHF antigen. J Lab Clin Med 1972; 80: 822-833
• 16 Stibbe J, Kirby EP. The influence of haemaccel fibrinogen and albumin on ristocetin-induced platelet aggregation. Relevance to the quantitative measurement of the ristocetin cofactor Thromb Res 1976; 8: 151-165
• 17 Bowman RP, Head DR, Marmer DJ, Broissot TD. Improved von Willebrand’s assay using ristocetin with standardized fixed-frozen platelets. Abstract 19th Annual Meeting of Am Soc Hematol; Boston: 1976
• 18 Wahlberg T, Blombäck M. Improved detection of haemophilia A carriers by factor VIII related antigen (radioimmunoassay) and bleeding symptoms. Thromb Res 1981; 21: 339-346
• 19 Hall P. Periodic health evaluation of individuals. In: Wagner G, Reichertz PL, Masè E. (Eds) Technology and Health: Man and his world. Lecture notes in medical informatics. Vol 7 pp 25-41 Springer; Berlin, Heidelberg, New York: 1980
• 20 Wahlberg T, Blombäck M, Hall P, Axelsson G. Application of indicators predictors and diagnostic indices in coagulation disorders. II. Evaluation of laboratory variables with continuous test results. Meth Inform Med 1980; 19: 201-205
• 21 Blombäck M, Hall P, Wahlberg T. Prediktorer och indikatorer vid analys av laboratoriefynd vid von Willebrand’s sjukdom. Läkartidningen 1978; 75: 2306-2310
• 22 Lachenbruch PA, Clarke WR. Discriminant analysis and its application in epidemiology. Meth Inform Med 1980; 19: 220-226
• 23 Italian working group. Spectrum of von Willebrand’s disease. Br J Haematol 1977; 35: 101-112
• 24 Nyman D, Eriksson AW, Blombäck M, Frants RR, Wahlberg P. Recent investigations of the first bleeder family in Åland (Finland) described by von Willebrand. Thromb Haemostas 1981; 45: 73-76
• 25 von Willebrand EA. Hereditär pseudohämofili. Finska läkarsällskapets Handlingar 1926; 68: 87-112
• 26 Solberg HE, Skrede S, Blomhoff JP. Diagnosis of liver diseases by laboratory results and discriminant analysis. Scand J Clin lab Invest 1975; 35: 713-721